FDA Food recall · Reported August 15, 2018
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Seroyal International, a division of Atrium Innovations recalled Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule … - a moderate-severity action.
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule … was recalled by Seroyal International, a division of Atrium Innovations in August 15, 2018. Reason: Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.. Check the official notice for the remedy. Verify recall #F-1756-2018 with the FDA Food before acting.
The recall
Seroyal International, a division of Atrium Innovations issued this moderate-severity FDA Food recall-Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification..
- Moderate
- severity level
- Class II
- classification
- August 15, 2018
- reported
Sourced from official FDA Food enforcement records. Verify recall #F-1756-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
Recall Insight
This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Drugs & Medications recalls over time
Where this recall sits in its category - 14,472 drugs & medications recalls on record
Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Product description
Genestra brand AFA-gen capsule 15 mg Niacin/ capsule 300 mg Blue Green Algae / capsule 2 capsules, twice daily Dietary supplement 90 capsules, White 150cc HDPE Bottle with Desiccant and white cap, packed as 12 bottles / shipper case
Reason for recall
Microcystins level found to be above the specification limit of NMT1 ppm as per Raw Material Specification.
Recall Profile
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | F-1756-2018 |
| Date reported | August 15, 2018 |
| Date initiated | July 27, 2018 |
| Recalling firm | Seroyal International, a division of Atrium Innovations |
| Firm location | Richmond Hill, Ontario |
| Affected scope | 4,226 bottles (1691 Canada and 2535 USA) |
| Distribution | Product was distributed throughout the United States and Canada (see attached document for list of Canadian consignees). |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
- Check the recall number (F-1756-2018) and product description against the item you own. Search the archive
- Confirm the current status with FDA Food before acting, recall details can be updated.
- Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Frequently Asked Questions
What product was recalled? ▼
Why was this product recalled? ▼
Which agency issued this recall? ▼
Where was the recalled product distributed? ▼
What are the health risks of consuming a recalled food product? ▼
Nationwide recalls with similar severity or category timing
Food and dietary-supplement notices outside this firm and state, matched by severity timing and product category.
Similar severity · nearest report date
Same archive severity grade (Moderate), closest by report date among other firms and states.
Similar Drugs & Medications · nearest report date
Same product category, closest by report date among other firms and states (deduped against the severity set).
Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls
Methodology · Corrections · Archive as of August 2026